RELATED CONTENT
NEWS
- Merck Serono safinamide boomerang 'completely unexpected' by Newron acquisitor BioTie
- Newron plans US clinical trial of anti-schizophrenia drug
- Asian safinamide deal with Meiji Seika a partial salve for Newron
- Zambon exercises option on Merck reject safinamide as Newron shakes off the old
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

